Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06699771
What this trial is testing

Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies

Who this might be right for
Lymphoma, T-Cell
GC Cell Corporation 53
Early research (Phase 1)Study completedNCT01900509
What this trial is testing

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaAcute Leukemia
St. Jude Children's Research Hospital 16
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)Study completedNCT03213691
What this trial is testing

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+8 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Looking for participantsNCT07489989
What this trial is testing

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu 30
Testing effectiveness (Phase 2)UnknownNCT01811368
What this trial is testing

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Joseph Tuscano 20
Testing effectiveness (Phase 2)Ended earlyNCT00655668
What this trial is testing

A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
T-cell Non-Hodgkin's Lymphoma
Celgene 54
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Early research (Phase 1)Study completedNCT02086604
What this trial is testing

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Washington University School of Medicine 37
Testing effectiveness (Phase 2)Study completedNCT00021372
What this trial is testing

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 25
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableLooking for participantsNCT07609030
What this trial is testing

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Multiple MyelomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more
Ohio State University Comprehensive Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT00711828
What this trial is testing

Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma

Who this might be right for
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more
Mayo Clinic 21
Very early researchLooking for participantsNCT04603872
What this trial is testing

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryAcute Lymphoblastic Leukemia, in Relapse+3 more
Zhejiang University 120
Testing effectiveness (Phase 2)UnknownNCT04021992
What this trial is testing

GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Sun Yat-sen University 48
Testing effectiveness (Phase 2)UnknownNCT05651100
What this trial is testing

Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Kecellitics Biotech Company Ltd 50
Not applicableStudy completedNCT03742921
What this trial is testing

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Celgene 150
Early research (Phase 1)Study completedNCT00718757
What this trial is testing

Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkins LymphomaHodgkin's DiseaseAcute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 4
Testing effectiveness (Phase 2)Study completedNCT00005824
What this trial is testing

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Early research (Phase 1)Study completedNCT05075603
What this trial is testing

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Who this might be right for
Refractory Diffuse Large B-cell LymphomaRecurrent Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma+2 more
NeoImmuneTech 17
Next Page